Literature DB >> 31668539

Flow disturbances and the development of endocardial fibroelastosis.

Viktoria Weixler1, Gerald R Marx2, Peter E Hammer1, Sitaram M Emani1, Pedro J Del Nido1, Ingeborg Friehs3.   

Abstract

OBJECTIVES: Endothelial-to-mesenchymal transition (EndMT) has been identified as the underlying mechanism of endocardial fibroelastosis (EFE) formation. The purpose of this study was to determine whether hemodynamic alterations due to valvar defects promote EndMT and whether age-specific structural changes affect ventricular diastolic compliance despite extensive surgical resection of EFE tissue.
MATERIAL AND METHODS: We analyzed EFE tissue from 24 patients with hypoplastic left heart syndrome (HLHS) who underwent left ventricular (LV) rehabilitation surgery at Boston Children's Hospital between December 2011 and March 2018. Six patients with flow disturbances across the aortic valve and/or mitral valve but no HLHS diagnosis and macroscopic appearance of "EFE-like tissue" in the LV were included for comparison. All samples were examined for amount of collagen/elastin production and degradation, and presence of active EndMT by histologic analysis.
RESULTS: EFE tissue from patients with and without HLHS consisted predominantly of elastin and collagen fibers. There was no alteration in degradation activity for collagen or elastin as shown by in situ zymography. Active EndMT was found in all patients with and without HLHS with flow disturbances ("EFE-like"). In patients with HLHS, EFE infiltrated into the underlying myocardium with increasing age.
CONCLUSIONS: Patients with and without HLHS with flow disturbances due to stenotic or incompetent valves develop EndMT-derived fibrotic tissue covering the LV. When EFE recurs, it is directly associated with flow disturbances and switches to an infiltrative growth pattern with increasing age, leading to increased diastolic stiffness of the LV.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  endocardial fibroelastosis; endothelial-to-mesenchymal transition; hypoplastic left heart syndrome

Mesh:

Substances:

Year:  2019        PMID: 31668539     DOI: 10.1016/j.jtcvs.2019.08.101

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Mechanical strain triggers endothelial-to-mesenchymal transition of the endocardium in the immature heart.

Authors:  Carina Vorisek; Viktoria Weixler; Massiel Dominguez; Roland Axt-Fliedner; Peter E Hammer; Ruei-Zeng Lin; Juan M Melero-Martin; Pedro J Del Nido; Ingeborg Friehs
Journal:  Pediatr Res       Date:  2021-11-26       Impact factor: 3.953

Review 2.  The Mechanobiology of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease.

Authors:  Shahrin Islam; Kristina I Boström; Dino Di Carlo; Craig A Simmons; Yin Tintut; Yucheng Yao; Jeffrey J Hsu
Journal:  Front Physiol       Date:  2021-09-09       Impact factor: 4.755

3.  Abnormal Flow Conditions Promote Endocardial Fibroelastosis Via Endothelial-to-Mesenchymal Transition, Which Is Responsive to Losartan Treatment.

Authors:  Nicholas A Oh; Xuechong Hong; Ilias P Doulamis; Elamaran Meibalan; Teresa Peiseler; Juan Melero-Martin; Guillermo García-Cardeña; Pedro J Del Nido; Ingeborg Friehs
Journal:  JACC Basic Transl Sci       Date:  2021-12-27

4.  Endothelial-to-Mesenchymal Transition as Underlying Mechanism for the Formation of Double-Chambered Right Ventricle.

Authors:  Viktoria Weixler; Peter Kramer; Judith Lindner; Peter Murin; Mi-Young Cho; Pedro Del Nido; Joachim Photiadis; Ingeborg Friehs
Journal:  Pediatr Cardiol       Date:  2022-01-27       Impact factor: 1.655

Review 5.  The Left Ventricular Myocardium in Hypoplastic Left Heart Syndrome.

Authors:  Bill Chaudhry; Ahlam Alqahtani; Lorraine Eley; Louise Coats; Corina Moldovan; Srinivas R Annavarapu; Deborah J Henderson
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.